TKMR
Arbutus Biopharma Corporation
A clinical-stage biopharmaceutical company working toward a cure for chronic hepatitis B, developing therapies that attack the virus at different stages of its lifecycle. Founded in 2005 as Tekmira Pharmaceuticals, it took the name Arbutus in 2015 after combining with OnCore BioPharma. The name honors the arbutus, a North American plant long valued for its healing properties—a fitting symbol for a company devoted to restoring health.
CUSIP: 87911B209HealthcareCA1 holder
Total Value
$119.0K
Total Shares
25.0K
Net Share Change
+25.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
